Contineum Therapeutics
CTNM
#6725
Rank
NZ$0.79 B
Marketcap
$30.78
Share price
-0.81%
Change (1 day)
N/A
Change (1 year)

Contineum Therapeutics (CTNM) - Cash on Hand

Cash on Hand as of June 2024 : NZ$0.36 Billion

According to Contineum Therapeutics's latest financial reports the company has NZ$0.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Contineum Therapeutics - Cash on Hand chart (from 2022 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.19 B166.06%
2022-12-31NZ$74.4 M-26.35%
2021-12-31NZ$0.10 B